Document Detail


Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A prospective study of 216 patients.
MedLine Citation:
PMID:  24370285     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
INTRODUCTION: Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) have demonstrated promising results in the treatment of peritoneal carcinomatosis (PC). The purpose of this study was to assess the impact of this combined procedure on quality of life (QoL).
MATERIALS AND METHODS: A prospective single centre study of 216 consecutive patients treated with CRS and HIPEC was conducted using the Gastro-Intestinal Quality of Life Index questionnaire (GIQLI), completed preoperatively and at 1, 3, 6 and 12 months.
RESULTS: Questionnaire compliance was 81%, 90%, 89%, 89% and 74% at baseline, 1, 3, 6 and 12 months respectively. QoL was significantly decreased up to 6 months and returned to baseline at 12 months. In multivariate analysis, factors decreasing QoL were origin of PC at 3 months, presence of stoma at 6 months and length of surgery over 270 min and disease recurrence at 12 months.
CONCLUSIONS: Despite morbidity associated with CRS and HIPEC, QoL returned to baseline at one year after surgery. This treatment strategy should be considered for the treatment of peritoneal carcinomatosis.
Authors:
G Passot; N Bakrin; A S Roux; D Vaudoyer; F-N Gilly; O Glehen; E Cotte
Related Documents :
16086115 - Risk factors for pancreas-related abscess after total gastrectomy.
23429485 - Does extensive upper abdomen surgery during primary cytoreduction impact on long-term q...
23025325 - Seventy-two total knee arthroplasties performed in patients with haemophilia using cont...
24115115 - Long term functional and quality of life evaluation after treatment of advanced pharyng...
24118425 - Psoralen-narrowband uvb phototherapy in treatment of vitiligo in comparison to narrowba...
10560995 - Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for th...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-12-14
Journal Detail:
Title:  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology     Volume:  -     ISSN:  1532-2157     ISO Abbreviation:  Eur J Surg Oncol     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2013-12-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8504356     Medline TA:  Eur J Surg Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing ...
Next Document:  [Changes of cell factor in bronchoalveolar lavage fluid in rats exposed to silica].